Upcoming Research Reveals Gender-Specific Risks in Antimicrobial Resistance

medical staff group of three workers with immune system shield and bottle drugs vector illustration design.

Upcoming research by the Global Strategy Lab’s AMR Policy Accelerator in collaboration with the World Health Organization (WHO) shows findings on gender-specific risks associated with antimicrobial resistance (AMR). A recent article by the Financial Times highlights key findings from this analysis. For more detailed insights, you can read the full article on the financial times website here.

The study showed that women, especially in low-resource areas, face higher risks of drug resistant infections due to biological, cultural, social, and economic factors. Their findings, based on 130, studies will be formally published on July 11th during a WHO webinar on gender inequalities and national action pans on antimicrobial resistance.

Previous

June 7, 2024

AMR Policy Accelerator and WHO Study Highlights Gender Inequities in AMR

Next

July 17, 2024

Highlights from the ReAct Africa and South Centre Annual Conference 2024